Article 1
1. Without prejudice to other Community legislation, in particular Council Directives 66/402/EEC (6) and 70/457/EEC (7) and Regulation (EC) No 258/97 of the European Parliament and the Council (8), and subject to paragraph 2 of this Article, consent shall be given by the competent authorities of France to the placing on the market of the following product, notified by AgrEvo France (Ref. C/F/95/12/07): seeds and grains of genetically modified maize (Zea mays L.) with increased glufosinate ammonium tolerance derived from the maize line HE/89 transformation event T25 which has been transformed using plasmid pUC/Ac containing: (a) a synthetic pat gene coding for phosphinothricine acetyl transferase under the regulation of a 35S promoter and terminator sequences from Cauliflower Mosaic Virus, and (b) a truncated beta-lactamase gene missing about 25 % of the gene from the 5' end, which when complete, codes for betalactam antibiotic resistance and the Col E1 origin of replication of pUC. 2. The consent shall cover any progeny derived from crosses of the product with any traditionally bred maize.